Wolverine Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Wolverine Trading’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25,070	Closed	-$145K	–	5524
2019 Q3	$92K	Buy	+25,070	New	+$96.7K	﹤0.01%	3876
2018 Q3	–	Sell	-28,096	Closed	-$83.7K	–	6327
2018 Q2	$104K	Hold	28,096	–	–	﹤0.01%	4713
2018 Q1	$104K	Buy	+28,096	New	+$91.9K	﹤0.01%	4713

Wolverine Trading's ACHN Position: Q4 2019 in Review

Wolverine Trading sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 25,070 shares — an estimated $145K sold.

Wolverine Trading first reported a position in ACHN in Q1 2018 and held it in 3 quarters. The position peaked at $104K in Q2 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Wolverine Trading reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Wolverine Trading sold 25,070 Achillion Pharmaceuticals shares in Q4 2019, an estimated $145K.
Wolverine Trading first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 3 quarters.
Wolverine Trading's Achillion Pharmaceuticals position peaked at $104K in Q2 2018.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.